Abstract:Background: Prior studies indicate that lactylation regulates various biological mechanisms within cancer. However, lactylation-related genes (LRGs) have been found to have limited value in predicting the prognosis of hepatocellular carcinoma (HCC). The aim of this study was to review HCC LRGs using data from The Cancer Genome Atlas (TCGA). Methods: The RNA sequencing data and related clinical information of patients with HCC patients were collected from the TCGA database. A total of 20 LRGs were selected and bioinformatics analysis was performed. A consistency cluster analysis was conducted to classify the HCC tumors. Using a lactylation-related model of HCC, prognosis, immune cell infiltration, and immunotherapy was evaluated. Results: A total of 4,378 genes were associated with prognosis. Twenty LRGs (i.e., ACIN1, RAN, PPP1CB, ALDOB, SUMO2, THOC2, HDAC1, SF3A1, SF3B1, HNRNPM, PPP1CC, SRRM1, PRPF6, HDAC2, H2AFV, ALYREF, H2AFZ, H2AFX, HNRNPK, and MAGOH) were identified. The 20 LRGs were used to divide TCGA-HCC patients into low-risk (G1) and high-risk (G2) categories. The upregulated genes in the G1 group primarily participate in the p53 signaling pathway, focal adhesion, extracellular matrix (ECM)-receptor interaction, and cell cycle, while the downregulated genes primarily participate in the glycolysis/gluconeogenesis, carbon metabolism, and biosynthesis of amino acids. The box plots showed a significant difference in the immune cell populations, with a higher abundance of B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and myeloid dendritic cells in the G1 than the G2 HCC samples. Further, the box plots showed higher expression levels of seven of the eight immune checkpoint inhibitor (ICI)-related genes in the G1 HCC samples than the G2 samples. There was a significant disparity in the cancer stem cell (CSC) scores between the G1 and G2 TCGA-HCC patients. Additionally, the G1 TCGA-HCC patients had higher tumor immune dysfunction and exclusion (TIDE) scores than the G2 TCGA-HCC patients. The prognosis of the HCC patients was also predicted using a six-LRG model, comprising HDAC2, SRRM1, SF3B1, HDAC1, THOC2, and PPP1CB. Conclusions: Strong correlation between LRGs and tumor classification as well as immunity in patients with HCC was identified. LRG signatures serve as reliable prognostic markers for HCC.

Comparative Proteomics Analysis of the Proteins Associated with Laryngeal Carcinoma‐Related Gene 1

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Development of an Immunogenomics-Based Prognostic Index Model of Laryngeal Squamous Cell Carcinoma

[Analysis of differential proteins in laryngeal carcinoma cell line Hep-2 with transfection of LCRG1].

Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.

Quantitative proteomics approach to screening of potential diagnostic and therapeutic targets for laryngeal carcinoma.

Screening and Mass Spectrometry Analysis of Differentially Expressed Proteins of Plasm Between Laryngocarcinoma and Healthy Individuals

Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.

[Comparative Proteome Analysis of Laser Capture Microdissection for Purified Primary Tumor and Lymph Node Metastatic Tumor in Human Lung Squamous Carcinoma].

LCRG1 Suppresses Tumor Growth in Vivo by Liposome-Mediated Gene Transfer

Identification and Significance of Differential Proteins in A549 Cells Transfected with HLCDG1

[A Preliminary Study on Genome-Wide Expression Profiling of Laryngeal Squamous Cell Carcinoma].

Isolation and Identification of Cdna Sequences Differentially Expressed in Laryngeal Carcinoma.

Differential Gene Expression Profiling of Laryngeal Squamous Cell Carcinoma by Laser Capture Microdissection and Complementary Dna Microarrays

Identification of a lactylation-related gene signature to characterize subtypes of hepatocellular carcinoma using bulk sequencing data

Detection Of Differentially Expressed Genes And Association With Clinicopathological Features In Laryngeal Squamous Cell Carcinoma

Preliminary proteomic analysis of human serum from patients with T1 glottic laryngeal carcinoma

Molecular cloning, identification and analysis of lung squamous cell carcinoma-related genes.

Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer

Identification of Differentially Expressed Genes in the Gastric Cancer Patient by Laser Microdissection and Cdna Microarray

Potential Prognostic Markers and Significant Lncrna-Mrna Co-Expression Pairs in Laryngeal Squamous Cell Carcinoma